Advisory Committee on Immunization Practices (ACIP); Correction, 83089 [2020-28091]
Download as PDF
<![CDATA[
83089
Federal Register / Vol. 85, No. 245 / Monday, December 21, 2020 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of respondent
Participants in survey group examining POC
NAT acceptability.
Participants in cross-sectional comparison of
several point-of-care NATs.
Acceptability/feasibility assessment among clinical and community providers.
Total ...............................................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–28113 Filed 12–18–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2020–0122]
Advisory Committee on Immunization
Practices (ACIP); Correction
Notice is hereby given of a change in
the meeting of the Advisory Committee
on Immunization Practices (ACIP);
December 11, 2020, 12:00 p.m.–5:00
p.m., EST; and December 13, 2020,
12:00 p.m.–4:00 p.m., EST (times
subject to change, see the ACIP website
for any updates: https://www.cdc.gov/
vaccines/acip/) which was
published in the Federal Register on
December 9, 2020, Volume 85, Number
237, pages 79814–79815.
The meeting dates and times should
read as follows:
DATES:
The meeting will be held on
December 11, 2020 from 12:00 p.m. to
5:00 p.m., EST and December 12, 2020
from 11:00 a.m. to 3:00 p.m., EST (times
subject to change, see the ACIP website
for any updates: https://www.cdc.gov/
vaccines/acip/).
Written comments must be received
on or before December 14, 2020.
The meeting is open to the public.
FOR FURTHER INFORMATION CONTACT:
Stephanie Thomas, ACIP Committee
Management Specialist, Centers for
Disease Control and Prevention,
National Center for Immunization and
VerDate Sep<11>2014
22:33 Dec 18, 2020
Jkt 253001
Number of
responses per
respondent
Number of
respondents
Form name
Release of information
form.
Study visit survey .........
POC NAT acceptability
survey.
Consent ........................
Release of information
form.
Study visit survey .........
POC NAT acceptability
survey, focus group,
or interview.
.......................................
1
10/60
42
250
87
1
1
15/60
20/60
63
29
250
250
1
1
30/60
10/60
125
42
250
25
1
1
15/60
1
63
25
........................
........................
........................
1,667
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–28091 Filed 12–18–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–21–20OJ]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘National YRBS
Test-Retest Reliability Study’’ to the
Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on June 2, 2020 to obtain
comments from the public and affected
agencies. CDC received no comments to
Frm 00063
Fmt 4703
Total burden
(in hours)
250
Respiratory Diseases, 1600 Clifton Road,
NE, MS–H24–8, Atlanta, GA 30329–
4027; Telephone: 404–639–8367; Email:
ACIP@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
PO 00000
Average
burden per
response
(in hours)
Sfmt 4703
the 60 day Federal Register Notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
E:\FR\FM\21DEN1.SGM
21DEN1
]]>Agencies
[Federal Register Volume 85, Number 245 (Monday, December 21, 2020)]
[Notices]
[Page 83089]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-28091]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2020-0122]
Advisory Committee on Immunization Practices (ACIP); Correction
Notice is hereby given of a change in the meeting of the Advisory
Committee on Immunization Practices (ACIP); December 11, 2020, 12:00
p.m.-5:00 p.m., EST; and December 13, 2020, 12:00 p.m.-4:00 p.m., EST
(times subject to change, see the ACIP website for any updates: https://www.cdc.gov/vaccines/acip/) which was published in the
Federal Register on December 9, 2020, Volume 85, Number 237, pages
79814-79815.
The meeting dates and times should read as follows:
DATES:
The meeting will be held on December 11, 2020 from 12:00 p.m. to
5:00 p.m., EST and December 12, 2020 from 11:00 a.m. to 3:00 p.m., EST
(times subject to change, see the ACIP website for any updates: https://www.cdc.gov/vaccines/acip/).
Written comments must be received on or before December 14, 2020.
The meeting is open to the public.
FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, ACIP Committee
Management Specialist, Centers for Disease Control and Prevention,
National Center for Immunization and Respiratory Diseases, 1600 Clifton
Road, NE, MS-H24-8, Atlanta, GA 30329-4027; Telephone: 404-639-8367;
Email: [email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-28091 Filed 12-18-20; 8:45 am]
BILLING CODE 4163-18-P
